
Analysis of Apellis Pharmaceuticals Inc (APLS), currently at $24.37, highlights two options strategies for yield enhancement. Selling a $22.00 strike put for a $1.25 premium offers a 5.68% return (32.90% annualized) if it expires worthless, with a 68% probability. Alternatively, a covered call strategy using a $27.00 strike call for a $1.25 premium could yield a 15.92% total return if the stock is called away, or a 5.13% return (29.70% annualized) if the call expires worthless, with a 53% probability, presenting specific risk/reward profiles for investors.
Apellis Pharmaceuticals Inc (APLS), currently trading at $24.37, presents opportunities for yield enhancement through specific options strategies, as indicated by the article's analysis. The implied volatility for both put (99%) and call (86%) options significantly exceeds the stock's trailing twelve-month actual volatility of 56%, suggesting potentially attractive premiums for options sellers. For investors interested in acquiring APLS shares at a discount, selling a cash-secured put at the $22.00 strike price for a $1.25 premium effectively lowers the cost basis to $20.75 if assigned. This out-of-the-money put has a 68% probability of expiring worthless, in which case the premium collected represents a 5.68% return (32.90% annualized) on the cash commitment. Existing APLS shareholders can consider a covered call strategy by selling the $27.00 strike call for a $1.25 premium. This strategy offers a potential total return of 15.92% if the stock is called away by the December 19th expiration. With a 53% probability of expiring worthless, the premium alone provides a 5.13% (29.70% annualized) boost to returns, allowing the investor to retain their shares while generating income. Both strategies offer distinct risk-reward profiles, with the put strategy targeting a lower entry point and the covered call strategy aiming for income generation and capped upside. The mildly positive sentiment (0.35) and low market impact score (0.15) suggest these are tactical plays rather than reactions to major market-moving news.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment